Nykredit A/S’s Genmab GMAB Stock Holding History

Nykredit A/S’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$57.6K	Buy	+2,097	New	+$55.7K	﹤0.01%	1465

Other funds holding GMAB

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return

Nykredit A/S's GMAB Position: Q2 2026 in Review

Nykredit A/S opened a new position in Genmab (GMAB) in Q2 2026: 2,097 shares worth $57.6K. The stake represents ﹤0.01% of the portfolio and ranks #1465 among its holdings.

218 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

Nykredit A/S held 2,097 shares of Genmab worth $57.6K as of Q2 2026.
Genmab was a new Nykredit A/S position in Q2 2026.
Genmab made up ﹤0.01% of Nykredit A/S's portfolio in Q2 2026, its #1465 holding.
218 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Nykredit A/S's 13F filing for Q2 2026, filed 13 Aug 2026.